33
Participants
Start Date
May 1, 2014
Primary Completion Date
June 29, 2023
Study Completion Date
June 29, 2023
NiCord®/CordIn™ (omidubicel)
Duke University Medical Center, Durham
Duke University Medical Center, Durham
Vanderbilt, Nashville
Hospital Universitario La Fe, Valencia
Loyola University, Cardinal Bernardin Cancer Center, Maywood
UCSF Benioff Children's Hospital, Oakland
National University Cancer Institute, Singapore
Singapore General Hospital, Singapore
University Medical Center Utrecht, Utrecht
University Hospital Vall D'Hebron, Barcelona
Lead Sponsor
Gamida Cell ltd
INDUSTRY